Lead Damage in the First-Year Following Cardiac Implantable Electronic Device (CIED) Replacement: Incidence and Costs Based on Device Type
Real-World Bleeding Risk among Non-Valvular Atrial Fibrillation (NVAF) Patients Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin: Analysis of Electronic Health Records
Clinical and Demographic Characteristics According to Dosage among Non-Valvular Atrial Fibrillation Patients Newly Initiated on Novel Oral Anticoagulants
Characteristics of Patients Initiating Oral Anticoagulant Therapy for Management of Non-Valvular Atrial Fibrillation (NVAF)
Outpatient Follow-Up Visits after Hospital Discharge for Mental Illness and Implications for Readmissions
An Assessment of Factors Associated with High Costs Among Patients with Multiple Sclerosis (MS) Receiving Disease-Modifying Drug (DMD) Therapy
An Assessment of Adherence Among Multiple Sclerosis Patients Newly Initiating Treatment with a Self-Injectable Versus Oral Disease-Modifying Drug
A Descriptive Analysis of Time to First Treatment with Disease-Modifying Drugs in Newly Diagnosed Patients with Multiple Sclerosis
Patterns Of Weight Change Before And After Lurasidone Initiation In Patients With Serious Mental Illness
